Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Print
Samira Merali, PharmD, MS
Senior Director, Clinical Pharmacology and Pharmacometrics
Bristol Myers Squibb
Poster(s):
072: Pharmacokinetics & Pharmacodynamics of Milvexian After Administration Every 12 Hours in Healthy Subjects
Sunday, September 8, 2024
5:00 PM – 7:00 PM
ET
149: Milvexian Does Not Prolong the QTc Interval: A Thorough QT Study in Healthy Subjects
Monday, September 9, 2024
5:00 PM – 7:00 PM
ET